The importance of drug discovery alliances between pharmaceutical industry and academic institutions is growing and gaining momentum due to increasing “needs” on both sides. Thereby the types of partnership are changing and novel models on how to collaborate are being explored. One key aspect is how to generate value for both partners out of these joint efforts.